Literature DB >> 17021183

Combination of thrombin and matrix metalloproteinase-9 exacerbates neurotoxicity in cell culture and intracerebral hemorrhage in mice.

Mengzhou Xue1, Morley D Hollenberg, V Wee Yong.   

Abstract

The rapid loss of neurons is a major pathological outcome of intracerebral hemorrhage (ICH). Several mechanisms may produce the neurotoxicity observed in ICH, and these include proteolytic enzymes such as thrombin and matrix metalloproteinase-9 (MMP-9). We tested the hypothesis that thrombin and MMP-9 combine to injure neurons in culture and that they interact to promote the acute neurotoxicity that occurs in ICH in vivo. We report that human fetal neurons die when exposed to thrombin or MMP-9 in isolation and that a combination of these two enzymes increased neurotoxicity. The toxicity of thrombin involved protease-activated receptor-1 and the conversion of proMMP-9 to active MMP-9. In ICH, which was induced in mice by the intracerebral injection of autologous blood, significant areas of brain damage, neuronal death, microglia/macrophage activation, and neutrophil accumulation occurred by 24 h of injury. Importantly, these neuropathological features were reduced in MMP-9 null mice compared with wild-type controls, and the concordant antagonism of thrombin using hirudin also alleviated the injury found in MMP-9 null mice. Our collective results demonstrate that thrombin and MMP-9 collaborate to promote neuronal death in culture and in ICH. To improve the prognosis of ICH, the neurotoxic actions of thrombin and MMP-9 must be inhibited early and simultaneously after injury.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17021183      PMCID: PMC6674619          DOI: 10.1523/JNEUROSCI.2806-06.2006

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  51 in total

1.  Intracerebral injection of autologous whole blood in rats: time course of inflammation and cell death.

Authors:  M Xue; M R Del Bigio
Journal:  Neurosci Lett       Date:  2000-04-14       Impact factor: 3.046

Review 2.  Protease-activated receptors: sentries for inflammation?

Authors:  T M Cocks; J D Moffatt
Journal:  Trends Pharmacol Sci       Date:  2000-03       Impact factor: 14.819

Review 3.  Spontaneous intracerebral hemorrhage.

Authors:  A I Qureshi; S Tuhrim; J P Broderick; H H Batjer; H Hondo; D F Hanley
Journal:  N Engl J Med       Date:  2001-05-10       Impact factor: 91.245

4.  Inhibition of cellular action of thrombin by N3-cyclopropyl-7-[[4-(1-methylethyl)phenyl]methyl]-7H-pyrrolo[3, 2-f]quinazoline-1,3-diamine (SCH 79797), a nonpeptide thrombin receptor antagonist.

Authors:  H S Ahn; C Foster; G Boykow; A Stamford; M Manna; M Graziano
Journal:  Biochem Pharmacol       Date:  2000-11-15       Impact factor: 5.858

5.  The protease thrombin is an endogenous mediator of hippocampal neuroprotection against ischemia at low concentrations but causes degeneration at high concentrations.

Authors:  F Striggow; M Riek; J Breder; P Henrich-Noack; K G Reymann; G Reiser
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

6.  Interleukin-1 is a key regulator of matrix metalloproteinase-9 expression in human neurons in culture and following mouse brain trauma in vivo.

Authors:  G G Vecil; P H Larsen; S M Corley; L M Herx; A Besson; C G Goodyer; V W Yong
Journal:  J Neurosci Res       Date:  2000-07-15       Impact factor: 4.164

7.  Metalloproteinase inhibition reduces thrombolytic (tissue plasminogen activator)-induced hemorrhage after thromboembolic stroke.

Authors:  P A Lapchak; D F Chapman; J A Zivin
Journal:  Stroke       Date:  2000-12       Impact factor: 7.914

8.  Matrix metalloproteinase-9/gelatinase B is required for process outgrowth by oligodendrocytes.

Authors:  L Y Oh; P H Larsen; C A Krekoski; D R Edwards; F Donovan; Z Werb; V W Yong
Journal:  J Neurosci       Date:  1999-10-01       Impact factor: 6.167

Review 9.  Plasticity-related serine proteases in the brain (review).

Authors:  S Yoshida; S Shiosaka
Journal:  Int J Mol Med       Date:  1999-04       Impact factor: 4.101

10.  Three-dimensional collagen matrices induce delayed but sustained activation of gelatinase A in human endothelial cells via MT1-MMP.

Authors:  M Nguyen; J Arkell; C J Jackson
Journal:  Int J Biochem Cell Biol       Date:  2000-06       Impact factor: 5.085

View more
  53 in total

1.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

Review 2.  The role of the microglia in acute CNS injury.

Authors:  Masahito Kawabori; Midori A Yenari
Journal:  Metab Brain Dis       Date:  2014-03-29       Impact factor: 3.584

Review 3.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

4.  Heme oxygenase 2 deficiency increases brain swelling and inflammation after intracerebral hemorrhage.

Authors:  J Wang; S Doré
Journal:  Neuroscience       Date:  2008-07-08       Impact factor: 3.590

5.  Hemoglobin-induced oxidative stress contributes to matrix metalloproteinase activation and blood-brain barrier dysfunction in vivo.

Authors:  Masataka Katsu; Kuniyasu Niizuma; Hideyuki Yoshioka; Nobuya Okami; Hiroyuki Sakata; Pak H Chan
Journal:  J Cereb Blood Flow Metab       Date:  2010-03-31       Impact factor: 6.200

6.  Protective effect of melatonin upon neuropathology, striatal function, and memory ability after intracerebral hemorrhage in rats.

Authors:  Tim Lekic; Richard Hartman; Hugo Rojas; Anatol Manaenko; Wanqiu Chen; Robert Ayer; Jiping Tang; John H Zhang
Journal:  J Neurotrauma       Date:  2010-03       Impact factor: 5.269

7.  The Molecular Mechanisms that Promote Edema After Intracerebral Hemorrhage.

Authors:  Daniel Bodmer; Kerry A Vaughan; Brad E Zacharia; Zachary L Hickman; E Sander Connolly
Journal:  Transl Stroke Res       Date:  2012-04-12       Impact factor: 6.829

8.  Chemokines and their receptors in intracerebral hemorrhage.

Authors:  Yao Yao; Stella E Tsirka
Journal:  Transl Stroke Res       Date:  2012-04-03       Impact factor: 6.829

9.  Src kinase inhibition decreases thrombin-induced injury and cell cycle re-entry in striatal neurons.

Authors:  Da-Zhi Liu; Xi-Yuan Cheng; Bradley P Ander; Huichun Xu; Ryan R Davis; Jeffrey P Gregg; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2008-02-09       Impact factor: 5.996

Review 10.  Cell cycle inhibition without disruption of neurogenesis is a strategy for treatment of central nervous system diseases.

Authors:  Da-Zhi Liu; Bradley P Ander; Frank R Sharp
Journal:  Neurobiol Dis       Date:  2009-11-24       Impact factor: 5.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.